Problems assessing uptake of Huntington disease predictive testing and a proposed solution

European Journal of Human Genetics

Volumn 17, Issue 1, 2009, Pages 66-70

  Tassicker, Roslyn J ^a   Teltscher, Betty ^b   Trembath, M Kaye ^c   Collins, Veronica ^c,d   Sheffield, Leslie J ^a,b,d   Chiu, Edmond ^b   Gurrin, Lyle ^b   Delatycki, Martin B ^a,b,c,d  

^a Genetic Health Services Victoria   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Bruce Lefroy Centre for Genetic Health Research   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; AUSTRALIA; CALCULATION; DIAGNOSTIC TEST; GENETIC ANALYSIS; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PEDIGREE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT;

AGE FACTORS; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; REGISTRIES; RISK ASSESSMENT; VICTORIA;

EID: 57649195915     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.142     Document Type: Article

References (16)

1. Taylor SD: Demand for predictive genetic testing for Huntington's disease in Australia, 1987 to 1993. Med J Aust 1994; 161: 351, 354-355.
2. Conneally PM: Guntington disease: genetics and epidemiology. Am J Hum Genet 1984; 36: 506-526.
3. Laccone F, Engel U, Holinski-Feder E et al: DNA analysis of Huntington's disease: Five years of experience in Germany, Austria, and Switzerland. Neurology 1999; 53: 801-806.
4. Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Roos R: Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiatry 2000; 69: 579-583.
5. Harper PS, Lim C, Craufurd D: Ten years of presymptomatic testing for Huntington's disease: The experience of the UK Huntington's Disease Prediction Consortium. J Med Genet 2000; 37: 567-571.
6. Goizet C, Lesca G, Durr A: Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002; 59: 1330-1336.
7. Creighton S, Almqvist EW, MacGregor D et al: Predictive, prenatal and diagnostic genetic testing for Huntington's disease: The experience in Canada from 1987 to 2000. Clin Genet 2003; 63: 462-475.
8. Tibben A, Frets PG, van de Kamp JJ et al: Presymptomatic DNA-testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 1993; 48: 10-16.
9. Bloch M, Fahy M, Fox S, Hayden MR: Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 1989; 32: 217-224.
10. Trembath MK, Tassicker RJ, Collins VR, Mansie S, Sheffield LJ, Delatycki MB: Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genet Med 2006; 8: 673-680.
11. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R: Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989; 2: 603-605.
12. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea: Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994; 31: 555-559.
13. Australian Bureau of Statistics. Demography Victoria: 3311.2, 2000. http://www.ausstats.abs.gov.au/Ausstats/subscriber.nsf/0/ 4F87599421188193CA256B250081F093/$File/33112_2000.pdf.
14. Roos RA, Hermans J, Vegter-van der Vlis M et al: Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993; 56: 98-100.
15. Foroud T, Gray J, Ivashina J et al: Differences in duration of Huntington's disease based on age at onset. J Neurol Neurosurg Psychiatry 1999; 66: 52-56.
16. Hayden M: Predictive testing for HuntinAton's disease: a universal model? Lancet Neurology 2003; 2: 141-142.